EUVIMEDEUVIMED entdecken
Open Access

LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity

Lawrence P Andrews, Samuel C Butler, Jian Cui, Anthony R Cillo, Carly Cardello, Chang Liu, Erin A Brunazzi, Andrew Baessler, Bingxian Xie, Sheryl R Kunning, Shin Foong Ngiow, Yinghui Jane Huang und 8 weitere

Cell · 2024-08 · 187 (16) · 4355-4372.e22

DOI: 10.1016/j.cell.2024.07.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-08. Verfasst von Lawrence P Andrews und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center…. Hauptthemen laut MEDLINE: Lymphocyte Activation Gene 3 Protein, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, Interferon-gamma. Die Arbeit wurde bisher 313-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte Activation Gene 3 ProteinProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesInterferon-gammaMice, Inbred C57BLAntigens, CDAnimalsMiceAutocrine CommunicationHumansMelanomaFemaleCell Line, TumorMelanoma, ExperimentalT-Cell Exhaustion

Stichwörter der Autor:innen

CD8(+) T cellIFN-γNKG2Aanti-LAG-3anti-PD-1anti-tumor immunityimmune checkpoint inhibitorimmuno-oncologyimmunotherapymelanoma

Substanzen

Lymphocyte Activation Gene 3 ProteinProgrammed Cell Death 1 ReceptorInterferon-gammaAntigens, CDLag3 protein, mousePdcd1 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UP…
  • Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine,…
  • Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • ORFDO NIH HHS
  • NIDA NIH HHS
  • NIH HHS
  • NIH
  • Bristol-Myers Squibb Co

Zitieren

APA

Andrews, L. P., Butler, S. C., Cui, J., Cillo, A. R., Cardello, C., Liu, C., Brunazzi, E. A., Baessler, A., Xie, B., Kunning, S. R., Ngiow, S. F., Huang, Y. J., Manne, S., Sharpe, A. H., Delgoffe, G. M., Wherry, E. J., Kirkwood, J. M., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2024). LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity. Cell, 187(16), 4355-4372.e22. https://doi.org/10.1016/j.cell.2024.07.016

Vancouver

Andrews LP, Butler SC, Cui J, Cillo AR, Cardello C, Liu C, et al. LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity. Cell. 2024;187(16):4355-4372.e22. doi:10.1016/j.cell.2024.07.016

BibTeX
@article{Andrews2024,
  author = {Andrews, Lawrence P and Butler, Samuel C and Cui, Jian and Cillo, Anthony R and Cardello, Carly and Liu, Chang and Brunazzi, Erin A and Baessler, Andrew and Xie, Bingxian and Kunning, Sheryl R and Ngiow, Shin Foong and Huang, Yinghui Jane and Manne, Sasikanth and Sharpe, Arlene H and Delgoffe, Greg M and Wherry, E John and Kirkwood, John M and Bruno, Tulia C and Workman, Creg J and Vignali, Dario A A},
  title = {LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {16},
  pages = {4355--4372.e22},
  doi = {10.1016/j.cell.2024.07.016}
}
Kostenlos starten →